Maternal Asthma Rx Linked to Adverse Perinatal Outcomes
Discontinuing asthma medications in pregnancy associated with increased odds of birth at <37 and <32 weeks of gestation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.